Terms: = Skin cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Treatment
143 results:
1. Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer.
Anand S; Shen A; Cheng CE; Chen J; Powers J; Rayman P; Diaz M; Hasan T; Maytin EV
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103983. PubMed ID: 38281610
[TBL] [Abstract] [Full Text] [Related]
2. Harmine and Kaempferol treatment enhances NFATC1 and foxp3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract] [Full Text] [Related]
3.
Vaddi PK; Osborne DG; Nicklawsky A; Williams NK; Menon DR; Smith D; Mayer J; Reid A; Domenico J; Nguyen GH; Robinson WA; Ziman M; Gao D; Zhai Z; Fujita M
Front Immunol; 2023; 14():1173035. PubMed ID: 37197667
[TBL] [Abstract] [Full Text] [Related]
4. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments.
Liao P; Jiang M; Islam MS; Wang Y; Chen X
Front Immunol; 2023; 14():1097090. PubMed ID: 36865537
[TBL] [Abstract] [Full Text] [Related]
5. Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study.
Shui IM; Liu XQ; Zhao Q; Kim ST; Sun Y; Yearley JH; Choudhury T; Webber AL; Krepler C; Cristescu R; Lee J
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793874
[TBL] [Abstract] [Full Text] [Related]
6. Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma.
Gartrell RD; Enzler T; Kim PS; Fullerton BT; Fazlollahi L; Chen AX; Minns HE; Perni S; Weisberg SP; Rizk EM; Wang S; Oh EJ; Guo XV; Chiuzan C; Manji GA; Bates SE; Chabot J; Schrope B; Kluger M; Emond J; Rabadán R; Farber D; Remotti HE; Horowitz DP; Saenger YM
Oncoimmunology; 2022; 11(1):2066767. PubMed ID: 35558160
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell analysis of Sézary syndrome reveals novel markers and shifting gene profiles associated with treatment.
Borcherding N; Severson KJ; Henderson N; Ortolan LS; Rosenthal AC; Bellizzi AM; Liu V; Link BK; Mangold AR; Jabbari A
Blood Adv; 2023 Feb; 7(3):321-335. PubMed ID: 35390145
[TBL] [Abstract] [Full Text] [Related]
8. Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment.
Star P; Jackett LA; Cheung K; Wilmott JS; Ho G; Smith A; Long GV; Scolyer RA; Martin LK
Dermatol Ther; 2022 Jun; 35(6):e15472. PubMed ID: 35347815
[TBL] [Abstract] [Full Text] [Related]
9. CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma.
Bozhanova G; Hassan J; Appleton L; Jennings V; Foo S; McLaughlin M; Chan Wah Hak CM; Patin EC; Crespo-Rodriguez E; Baker G; Armstrong E; Chiu M; Pandha H; Samson A; Roulstone V; Kyula J; Vile R; Errington-Mais F; Pedersen M; Harrington K; Ono M; Melcher A
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35338089
[TBL] [Abstract] [Full Text] [Related]
10. Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.
Zhao X; Yue D; Qian J; Zhang L; Song J; Zhang B; Zhang C; Sun L; Ma Y; Zhang H; Wang C
Front Immunol; 2022; 13():794217. PubMed ID: 35173719
[TBL] [Abstract] [Full Text] [Related]
11. Pathogenesis of cutaneous T cell lymphoma: Involvement of Staphylococcus aureus.
Fujii K
J Dermatol; 2022 Feb; 49(2):202-209. PubMed ID: 34927279
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of programmed cell death ligand 1 (PD-L1) and inflammatory cells in basal cell carcinoma subtypes.
Gompertz-Mattar M; Perales J; Sahu A; Mondaca S; Gonzalez S; Uribe P; Navarrete-Dechent C
Arch Dermatol Res; 2022 Oct; 314(8):777-786. PubMed ID: 34647186
[TBL] [Abstract] [Full Text] [Related]
13. foxp3 Predicts Response to treatment in Mycosis Fungoides.
Perelman M; Rozenblat M; Ellenbogen E; Geller S; Slutsky Bank E; Eytan O; Gat A; Sprecher E; Goldberg I
Acta Dermatovenerol Croat; 2021 Jul; 29(2):67-71. PubMed ID: 34477071
[TBL] [Abstract] [Full Text] [Related]
14. Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.
Banerjee A; Li D; Guo Y; Mahgoub B; Paragas L; Slobin J; Mei Z; Manafi A; Hata A; Li K; Shi L; Westwick J; Slingluff C; Lazear E; Krupnick AS
J Immunol; 2021 Jul; 207(1):333-343. PubMed ID: 34155069
[TBL] [Abstract] [Full Text] [Related]
15. A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy.
Wang Y; Gu T; Tian X; Li W; Zhao R; Yang W; Gao Q; Li T; Shim JH; Zhang C; Liu K; Lee MH
Front Immunol; 2021; 12():654463. PubMed ID: 34054817
[TBL] [Abstract] [Full Text] [Related]
16. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract] [Full Text] [Related]
17. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.
Somasundaram R; Connelly T; Choi R; Choi H; Samarkina A; Li L; Gregorio E; Chen Y; Thakur R; Abdel-Mohsen M; Beqiri M; Kiernan M; Perego M; Wang F; Xiao M; Brafford P; Yang X; Xu X; Secreto A; Danet-Desnoyers G; Traum D; Kaestner KH; Huang AC; Hristova D; Wang J; Fukunaga-Kalabis M; Krepler C; Ping-Chen F; Zhou X; Gutierrez A; Rebecca VW; Vonteddu P; Dotiwala F; Bala S; Majumdar S; Dweep H; Wickramasinghe J; Kossenkov AV; Reyes-Arbujas J; Santiago K; Nguyen T; Griss J; Keeney F; Hayden J; Gavin BJ; Weiner D; Montaner LJ; Liu Q; Peiffer L; Becker J; Burton EM; Davies MA; Tetzlaff MT; Muthumani K; Wargo JA; Gabrilovich D; Herlyn M
Nat Commun; 2021 Jan; 12(1):346. PubMed ID: 33436641
[TBL] [Abstract] [Full Text] [Related]
18. Presence of tumor-infiltrating CD8
Johansson J; Siarov J; Kiffin R; Mölne J; Mattsson J; Naredi P; Olofsson Bagge R; Martner A; Lindnér P
Oncoimmunology; 2020 Dec; 9(1):1854519. PubMed ID: 33344043
[TBL] [Abstract] [Full Text] [Related]
19. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Qin Y; Bollin K; de Macedo MP; Carapeto F; Kim KB; Roszik J; Wani KM; Reuben A; Reddy ST; Williams MD; Tetzlaff MT; Wang WL; Gombos DS; Esmaeli B; Lazar AJ; Hwu P; Patel SP
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203661
[TBL] [Abstract] [Full Text] [Related]
20. Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma.
Sabbatino F; Scognamiglio G; Liguori L; Marra A; Anniciello AM; Polcaro G; Dal Col J; Caputo A; Peluso AL; Botti G; Zeppa P; Ferrone S; Pepe S
Front Immunol; 2020; 11():561390. PubMed ID: 33117345
[TBL] [Abstract] [Full Text] [Related]
[Next]
